← Open Payments lookup

MARK LASSISE: Open Payments

NPI 1023002508 · MASON CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$998 in 50 payments from 12 companies in 2025. Trend: 2023 $929 · 2024 $955 · 2025 $998

Food & beverage: $998
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$263
ABBVIE INC.11$194
Teva Pharmaceuticals USA, Inc.6$143
Neurocrine BioSciences, Inc.6$118
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$60
Axsome Therapeutics, Inc.3$55
Janssen Pharmaceuticals, Inc3$53
E.R. Squibb & Sons, L.L.C.2$35
Lundbeck LLC1$27
Vanda Pharmaceuticals Inc.1$19

Products named: REXULTI, VRAYLAR, INGREZZA, UZEDY, AUSTEDO XR, CAPLYTA, Auvelity, ABILIFY ASIMTUFII.

Industry payments across IA — which companies pay providers there.